Additionally, both GLP-1 and GIP play a role in cardiovascular disease, as agonists of GLP-1 have been shown to reduce platelet activation, thus supporting a protective effect of GLP-1 against microvascular thrombosis [24]
In 2021, diabetes was responsible for 6.7 million deaths across the world and a healthcare expenditure of USD 966 billion
Most people dont have this issue, but for those who do, it can feel unsettling. According to Hosam Hmoud, MD, cardiology fellow at Northwell Lenox Hill Hospital, while the research and clinical trials we have so far on Ozempic and other GLP-1s dont include heart palpitations or arrhythmias as side effects, some studies have actually shown the opposite
Many factors that dramatically alter other medications have minimal impact on tirzepatide duration
How long does semaglutide heartburn last